Table 3 .
Postrandomisation acquisition of infection and colonisation
| Variable | Experimental group (n=30) | Controls (n=28) | RR (95% CI) | p |
|---|---|---|---|---|
| Acquired infections | ||||
| At day 3 | 1/18 (6%) | 1/19 (5%) | 1.06 (0.07 to 15.64) | 1.00 |
| At day 5 | 1/18 (6%) | 2/19 (11%) | 0.53 (0.05 to 5.33) | 1.00 |
| At any time post-randomisation | 2/18 (11%) | 3/19 (16%) | 0.70 (0.13 to 3.73) | 1.00 |
| Nasal swabs | ||||
| MRSA | 1/28 (4%) | 2/25 (8%) | – | 0.60 |
| Rectal swabs | ||||
| ESBL | 1/25 (4%) | 0/22 (0%) | – | 1.00 |
| Enterobacter Klebsiella | 0/24 (0%) | 0/24 (0%) | – | – |
ESBL, extended spectrum β-lactamase-resistant; MRSA, methicillin-resistant Staphylococcus aureus; RR, relative risk.